DR. REDDY'S LAB LTD ADR (NY:RDY)
23.66
+0.32 (1.37%)
| DR. REDDY'S LAB LTD ADR (NY:RDY) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $23.34 | 52 Week High | $27.33 | ||
| Open | $23.73 | 52 Week Low | $7.27 | ||
| Day High | $23.73 | P/E | N/A | ||
| Day Low | $23.13 | EPS | $0.00 | ||
| Volume | 511,705 | ||||
| More RDY Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| POZN | 1 | AMRI | 1 |
| TEVA | 1 | ||
Entities who have mentioned RDY
- Citi | View Related Stories »
- Friedman, Billings, Ramsey | View Related Stories »
- Goldman Sachs | View Related Stories »
- Dividend | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morgan Stanley | View Related Stories »
- Piper Jaffray | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
StreetInsider.com Major News for RDY
View All ReportsStreetInsider.com Reports on RDY
- Dr. Reddy's Labs (RDY) Posts Q3 EPS of $0.70, Better Y/Y; Revs Down
- Dr Reddy's (RDY) Shares Down as Deutsche Cuts to Sell
- Morgan Stanley Upgrades Dr. Reddy's Labs (RDY) to Overweight
- AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories (RDY) and Sandoz
- Pozen (POZN) Receives Notice from Dr. Reddy's Labs (RDY) Indicating Dr. Reddy's has Filed an ANDA to Market a Generic Version of Treximet
View All Press ReleasesCompany Press Releases on RDY
- Aegis Therapeutics and Dr. Reddy's Announce Strategic Alliance
- Dr. Reddy's Q3 FY10 Financial Results
- Dr. Reddy's to Release Q3 FY10 Results on Jan 20, 2010; Earnings Call Slated for Jan 20, 6.30 PM IST / 8.00 AM EST
- Dr. Reddy's and Rheoscience Announce Headline Results from First Phase III Clinical Trial of Balaglitazone (DRF 2593)
- Bodhtree's MIDAS to Help Solve Mission Critical Application Integration Challenges for Global Pharma Major Dr.Reddy's
StreetInsider Reports on RDY by Category
View All BlogsBlogs on RDY
- Indian Markets Thursday Wrap-Up: Six Day Losing Streak Snapped
- 20 'Babies with Bathwater' and 3 'Dogs with Fleas' Stocks for the Week
- Dr. Reddy’s Laboratories Limited F3Q10 (Qtr End 12/31/09) Earnings Call Transcript
- Indian Markets Wednesday Wrap-Up: Earnings, Global Cues Effect Sentiment
- Indian Markets Wednesday Wrap-Up: Earnings, Global Cues Affect Sentiment
Comments on RDY
No comments are currently available.
on Dec 16, 2009
at 04:41 PM dr. reddy's generic imitrex Dr. Reddy's generic imitrex works much better for me than the real imitrex. The problem is that the pharmacy will often only have another brand which does not work as well.
Article: Dr. Reddy’s (RDY) Launches Generic Imitrex
on Dec 15, 2009
at 03:17 PM Made by GSK for Dr. Reddy's Read the box!! It says "Manufactured by Penn Labs (a GlaxoSmithKline company) for Dr. Reddy's Laboratory Inc. Bridgewagter, NJ08807. Made in Singapore" So there you have it. It's the same stuff. It's widely known: when patents about to expire, companies contract with others to put a generic on the market and compete there as well. It says made in Singapore, well, I guess to save money (or to make more money)..
Article: Dr. Reddy’s (RDY) Launches Generic Imitrex
on Nov 18, 2009
at 06:34 PM cost of generic imitrex WHY DOES THE GENERIC COST 30 DOLLARS A PILL? WHAT A JOKE
Article: Dr. Reddy’s (RDY) Launches Generic Imitrex
on Jun 28, 2009
at 10:56 AM Generic Imitrex Report results to the Food and Drug Administration, (FDA). Only way to bring about a change.
Article: Dr. Reddy’s (RDY) Launches Generic Imitrex
on Mar 30, 2009
at 01:00 PM Dr. Reddy Makes me sick. I hate this pill! Made me lightheaded, sick to my stomach and I feel my headach is not going away.
Article: Dr. Reddy’s (RDY) Launches Generic Imitrex